当前位置: X-MOL 学术Lancet Global Health › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Limited access to CVD medicines in low-income and middle-income countries: poverty is at the heart of the matter
The Lancet Global Health ( IF 34.3 ) Pub Date : 2018-03-01 , DOI: 10.1016/s2214-109x(18)30048-2
Charles Agyemang , Bert-Jan van den Born

Non-communicable diseases (NCDs) pose a substantial threat to many health systems, especially in low-income and middle-income countries (LMICs) where they are already overstretched.1 In the past few decades, deaths from NCDs in LMICs have spiked, whereas numbers in high-income countries have stabilised.1 Worryingly, a large proportion of deaths from NCDs (29%) in LMICs occur among people younger than 60 years compared with the proportion in high-income countries (13%).1 This finding has been attributed to poor access to effective and equitable health-care services in most LMICs.

中文翻译:

低收入和中等收入国家获得CVD药物的机会有限:贫困是问题的核心

非传染性疾病(NCD)对许多卫生系统构成了重大威胁,尤其是在已经过度扩张的低收入和中等收入国家(LMIC)中。1在过去的几十年中,中低收入国家非传染性疾病的死亡人数激增,而高收入国家的人数则稳定下来。1令人担忧的是,低收入和中等收入国家死于非传染性疾病的比例很大(29%)发生在60岁以下的人群中,而高收入国家的这一比例是13%。1这一发现归因于大多数中低收入国家无法获得有效和公平的保健服务。
更新日期:2018-02-10
down
wechat
bug